Labor Pain Clinical Trial
Official title:
Cervical Capsaicin for Labor Induction and Pain Relief
In the setting of fetal demise it is important to help the mother deliver the fetus expeditiously and with as little physical trauma as possible. This study hypothesizes that application of capsaicin to the uterine cervix will enhance cervical ripening and desensitize pain fibers such that delivery is less painful.
Induction of labor is associated with increased risk of cesarean section and elevated pain when compared to labor of spontaneous onset. In the setting of intrauterine fetal demise (IUFD), it is desirable to induce labor in order to achieve a successful vaginal delivery for the health and well being of the mother, thereby avoiding operative fetal extraction. The current protocol for midtrimester labor induction prior to 24 weeks gestational age includes intravaginal cytotec(misoprostol) 200 mcg every 6 hours for up to 24 hours, occasionally followed by oxytocin infusion. When an IUFD occurs at 24 or greater weeks gestational age, labor is induced with cytotec 25 or 50 mcg every 4 hours and/or oxytocin infusion. The investigators hypothesize that application of lidocaine to the uterine cervix followed by 0.1% capsaicin cream will facilitate cervical ripening and decrease the pain of labor induction when compared to use of a placebo cream. Capsaicin 8methylNvannilyl6nonenamide) activates TRPV1, a nonselective cation channel activated directly by heat, and low pH, and indirectly by a number of inflammatory factors, including nerve growth factor (NGF), bradykinin, lipids, and prostaglandins. Activation of TRPV1 by capsaicin results in an influx of Ca2 and Na ions, depolarization, exocytosis of neuropeptides and excitatory amino acids, and induces a burning sensation. This initial phase is followed by prolonged desensitiztion that is dose dependent. Once the TRPV1 receptor is desensitized, pain transmission through Ctype primary afferent receptors is reduced. The pain relief from capsaicin is due to desensitization of the TRPV1 receptor. The enhancement of cervical ripening is due to activation of primary afferent Cfibers, release of neuropeptides substance P, neurokinin A, calcitonin generelated peptide, secretoneurin and nitric oxide to help orchestrate a series of local inflammatory responses including vasodilation, vascular permeability with tissue edema and protein extravasation, and migration of inflammatory immune cells. In a study of pregnant rats, vaginal lidocaine gel was applied followed by capsaicin sham cream. A blinded observer monitored behavior via video over the next 72 hours. All animals treated with capsaicin delivered on day 22 with minimal pain behaviors while 90% of sham treated animals delivered as expected on day 23 with normal pain related behavior. All pups were delivered live and rearing and suckling behavior was normal. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03539562 -
Therapeutic Rest to Delay Admission in Early Labor: A Prospective Study on Morphine Sleep
|
||
Withdrawn |
NCT04662450 -
Evaluation and Management of Parturients' Pain Intensity
|
N/A | |
Completed |
NCT02885350 -
Spinal or Epidural Fentanyl or Sufentanil for Labour Pain in Early Phase of the Labour
|
Phase 4 | |
Completed |
NCT02550262 -
Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor
|
N/A | |
Completed |
NCT01598506 -
Intrathecal Hydromorphone for Labor Analgesia
|
Phase 2 | |
Withdrawn |
NCT01636999 -
Comparing Sedara to Butorphanol in Early Labor
|
N/A | |
Completed |
NCT00987441 -
Epidural Labor Analgesia and Infant Neurobehavior
|
N/A | |
Completed |
NCT00755092 -
Effect of Doula in Nulliparas and Multiparas
|
N/A | |
Terminated |
NCT00787176 -
The Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes
|
N/A | |
Recruiting |
NCT06036797 -
Efficacy and Safety of Hydromorphone-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia
|
Phase 2 | |
Completed |
NCT05512065 -
Changes in Velocimetric Indices of Uterine and Umbilical Arteries Before and After Combined Spinal-epidural Analgesia in Laboring Women
|
N/A | |
Completed |
NCT05327088 -
Epidural Dexmedetomidine vs Nalbuphine for Labor Analgesia
|
Phase 2 | |
Completed |
NCT03103100 -
Comparing Bupivacaine, Lidocaine, and a Combination of Bupivacaine and Lidocaine for Labor Epidural Activation
|
Phase 3 | |
Recruiting |
NCT03623256 -
Comparison of Intrathecal Versus Epidural Fentanyl on Fetal Bradycardia in Labor Combined Spinal Epidural Analgesia
|
Phase 4 | |
Active, not recruiting |
NCT02271100 -
Assessment of the Use of Ultrasound for Epidural Catheter Placement and Comparison With Palpation Technique
|
N/A | |
Completed |
NCT02926469 -
Virtual Reality Analgesia in Labor: The VRAIL Pilot Study
|
N/A | |
Completed |
NCT03712735 -
Programmed Intermittent Epidural Bolus For Laboring Obstetrical Women
|
Phase 4 | |
Not yet recruiting |
NCT05565274 -
Outcome of Combined Tramadol and Paracetamol Versus Pentazocine as Labour Analgesia Among Parturients
|
N/A | |
Recruiting |
NCT01708668 -
The Effects of Intermittent Epidural Bolus on Fever During Labor Analgesia
|
N/A | |
Recruiting |
NCT02575677 -
Oxycodone in Treatment of Early Labour Pain Efficacy and Safety
|